An experimental personalized mRNA-based cancer vaccine from Merck and Moderna was successful at preventing melanoma from returning or spreading in a late-stage trial of high risk patients, the companies announced Wednesday. The positive results mean a potentially life-extending treatment is on...
Source: [The Hill](https://thehill.com/policy/healthcare/6038285-merck-moderna-melanoma-vaccine-success/)